Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs

Area of Science:

• Organometallic Chemistry
• Medicinal Chemistry
• Materials Science

Background:

• Titanocene and ansa-titanocene complexes are explored for their biological activities.
• Cytotoxicity of metal complexes is a key area in anticancer drug development.
• Understanding structure-activity relationships is crucial for designing effective therapeutic agents.

Purpose of the Study:

• To synthesize and characterize novel titanocene and ansa-titanocene complexes.
• To evaluate the cytotoxic activity of these complexes against various human tumor cell lines and normal cells.
• To investigate the influence of alkenyl substitution on cytotoxic efficacy.

Main Methods:

• Synthesis and characterization of titanocene and ansa-titanocene complexes.
• Cytotoxicity assays using human adenocarcinoma (HeLa), myelogenous leukemia (K562), and malignant melanoma (Fem-x) cell lines.
• Testing against peripheral blood mononuclear cells (PBMC) for selectivity.
• Density Functional Theory (DFT) calculations and X-ray crystallography for structural analysis.

Main Results:

• Titanocene complexes with alkenyl substitution on the cyclopentadienyl ring or ansa-bridge showed higher cytotoxicity (IC50 values from 24±3 to 151±10 μM).
• Complexes with additional alkenyl-substituted silyl groups on the silicon bridge exhibited reduced cytotoxicity (IC50 values from 155±9 to >200 μM).
• An analogous niobocene complex was synthesized, and structural studies were performed on active titanocenes.

Conclusions:

• Alkenyl substitution patterns significantly modulate the cytotoxic activity of titanocene complexes.
• Strategic placement of alkenyl groups is key to enhancing anticancer potential.
• These findings provide insights for the design of novel organometallic anticancer agents.